Drotrecogin alfa (activated) -: Treatment of septic shock

被引:1
|
作者
Sorbera, LA [1 ]
Martín, L [1 ]
Castañer, RM [1 ]
机构
[1] Prous Sci, Barcelona 08080, Spain
关键词
D O I
10.1358/dof.2001.026.05.620122
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:440 / 443
页数:4
相关论文
共 50 条
  • [41] Treatment of heparin-induced thrombocytopenia with drotrecogin alfa (activated)
    Rubeiz, GJ
    Marrone, CM
    Leclerc, JR
    PHARMACOTHERAPY, 2006, 26 (03): : 428 - 434
  • [42] Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
    H Mohamed
    AA Hameed
    M Al-Ansari
    Critical Care, 11 (Suppl 2):
  • [43] The safety profile of drotrecogin alfa (activated)
    Roberto Fumagalli
    Mariano A Mignini
    Critical Care, 11
  • [44] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [45] The safety profile of drotrecogin alfa (activated)
    Fumagalli, Roberto
    Mignini, Mariano A.
    CRITICAL CARE, 2007, 11 (Suppl 5):
  • [46] Effect of Drotrecogin alfa (activated) on Cytokeratin-18 levels in blood of septic patients
    Hoffmann, U.
    Behnes, M.
    Saur, J.
    Lang, S.
    Liebetrau, C.
    Borggrefe, M.
    INFECTION, 2011, 39 : S119 - S119
  • [47] Drotrecogin alfa (activated) in severe sepsis
    Janes, Jonathan M.
    Vangerow, Burkhard
    Costigan, Timothy M.
    Macias, William L.
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 108 - 109
  • [48] Drotrecogin alfa (activated): is there room for improvement?
    Cunningham, Kath
    Jankovic, Zorica
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (11) : 952 - 952
  • [49] Management challenge with drotrecogin alfa (activated)
    Vanscoy, GJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 : S23 - S27
  • [50] The rise and fall of drotrecogin alfa (activated)
    Vincent, Jean-Louis
    LANCET INFECTIOUS DISEASES, 2012, 12 (09): : 649 - 651